biomarin
BioMarin is a pioneering biotechnology company focused on developing transformative medicines for rare genetic diseases, leveraging scientific expertise in genetics and molecular biology. The company values bold science, innovation, and a commitment to addressing significant unmet medical needs.
Headquarters
San Rafael, California, United States
Company Size
1001-5000 employees
Founded
1997
BioMarin Pharmaceutical is a global biotechnology company that researches, develops, and commercializes therapies for rare genetic and lysosomal storage diseases. The company has brought medicines to market for conditions such as achondroplasia and severe hemophilia A and focuses on innovative modalities—including gene therapies and biologics—to address high unmet medical needs. BioMarin partners with clinicians, regulators, and patient communities to advance treatments from discovery through global regulatory approval and patient access.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for biomarin.
40% above the average for this role
Chief of Staff to CEO of BridgeBio and GondolaBio
BridgeBio Pharma
Associate Director, Marketing Operations
Beam Therapeutics
APTPUO-PT--Fall 2026 - HSS2705A
University of Ottawa
Associate Director, Drug Substance Development & Manufacturing
Entrada Therapeutics
POSTDOCTORAL RESEARCHER - GE – Metabolic Disease Genetics - Zhang Lab [Req#: 915232, Position#: 130357]
UT Southwestern Medical Center
Patient Affairs Intern
Sarepta Therapeutics